Page 54 - GM_2018_6

GLASS PACKAGING
Glass packaging
FEVE

shaping the future of the-over-

the-counter and biotech markets

During the recently-held CPhI Worldwide event in Madrid, FEVE hosted

a briefing to discuss over-the-counter and biotech markets, and how

glass packaging

suppliers should LAURENT ZUBER

adapt to best match Laurent Zuber joined SGD Group
in 2006 when Saint Gobain
Desjonqueres was sold to Private
their needs. &RVJUZ BOE EFmOFE UIF TUSBUFHZ UP
GVSUIFS FYUFOE MFBEJOH QPTJUJPO XJUI
TUSPOHFS NBSLFU TIBSFT JO BMM TFH-
NFOUT -BVSFOU ;VCFS IBT B EFFQ
LOPXMFEHF PG UIF 1IBSNB JOEV-
stry since 2002 and of the Glass
*OEVTUSZ TJODF -BVSFOU ;VCFS
JT DVSSFOUMZ $$0 BOE .BOBHJOH
%JSFDUPS PG 4(% 1IBSNB MFBEJOH
t CPhI Worldwide in
TBMFT NBSLFUJOH BDUJWJUJFT BT XFMM
Madrid on 10 October, BT UIF USBEJOH DPNQBOZ &NCFMJB
in a briefing held by *O UIF QBTU -BVSFOU ;VCFS IFME
A FEVE – the European TFWFSBM MFBEJOH QPTJUJPOT BU 4BJOU
Container Glass Federation, (PCBJO &NCBMMBHF OPX 7FSBMMJB
Laurent Zuber – CCO of SGD BOE 05*4 FMFWBUPST )F HSBEVB-
Pharma & Chairman of the FEVE UFE GSPN UIF *OTUJUVU 4VQÏSJFVS EF
Flaconnage Board, and Frédéric $PNNFSDF PG 1BSJT 'SBODF
Jailloux – Managing Director
of Val-U Advisory shared their
perspectives on the dynamics of business model integrating a very have an increasing central role
these two important market seg- high level of process capabili- as a marketing differentiator in
ments, and how packaging sup- ties, a full control of product/ the launch of new products, but
pliers, glass in primis, should packaging interaction, and cost also by providing key function-
adapt to best match their needs. effectiveness. alities in terms of safety, anti-
“Both segments are destined counterfeiting and convenience,
OTC – MOVING FROM to grow in the coming years, which is crucial for an ageing
PASSIVE TO ECO- and both will represent major population. Glass has always
CONSCIOUS PATIENTS opportunities for the packaging been the packaging of choice for
The OTC (over-the-counter) sector mainly driven by the abil- OTC for the well-known virtues
pharma market is driven by the ity to meet new market trends, of strength, weight, purity and
shift from a passive and unin- but also to answer to increasingly transparency, stated Mr Zuber.
formed patient to an eco-con- demanding compliance rules,” Its further usage will rely on its
scious and educated consumer. commented Frédéric Jailloux. capacity to adapt to new market
On the biotech side, the value Mr. Jailloux observed that in needs and to redefine itself as
chain is engaged to shape a new the OTC market, packaging will premium packaging material at

glass machinery plants & accessories 6/2018
52